Skip to main content

Algert Global LLC

SEC CIK
0001275218
Latest filing
Aug 13, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of RAPT by Algert Global LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−47,483−100.0%Sold outHolders
Q4 202447,483$75.0K<0.1%00.0%UnchangedHolders
Q3 202447,483$95.4K<0.1%00.0%UnchangedHolders
Q2 202447,483$144.8K<0.1%−6,405−11.9%ReducedHolders
Q1 202453,888$483.9K<0.1%+18,758+53.4%AddedHolders
Q4 202335,130$873.0K<0.1%−26,861−43.3%ReducedHolders
Q3 202361,991$1.03M<0.1%−13,450−17.8%ReducedHolders
Q2 202375,441$1.41M0.1%+1,490+2.0%AddedHolders
Q1 202373,951$1.36M0.1%+5,294+7.7%AddedHolders
Q4 202268,657$1.36M0.1%+54,980+402.0%AddedHolders
Q3 202213,677$329.0K<0.1%+2,112+18.3%AddedHolders
Q2 202211,565$211.0K<0.1%+11,565NewHolders
Q4 20210$00.0%−11,156−100.0%Sold outHolders
Q3 202111,156$346.0K<0.1%+2,356+26.8%AddedHolders
Q2 20218,800$280.0K0.1%−7,430−45.8%ReducedHolders
Q1 202116,230$360.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.